Drugs / GDC-3280
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02471859 | Jun → Dec 2015 | — | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GDC-3280 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02471859 ↗ |
| Route | Oral | “Single- and Multiple-Oral-Dose” NCT02471859 ↗ |